SEC Form 4Coverage since Jun 1, 2026
$FENC insider trading
Over the last 12 months, Fennec Pharmaceuticals insiders reported no purchases and 3 sales totaling $289K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $289K 3 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $FENC · 12Mvia TradingView
Top insiders · 12m
Raykov Rosty—3× · $289K
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Raykov Rosty | ▼ Sale | 10,000 | $9.58 | $96K | -7.1% | plan |
| Jul 1, 2026 | Raykov Rosty | ▼ Sale | 9,599 | $10.41 | $100K | -6.5% | plan |
| Jun 1, 2026 | Raykov RostyD | ▼ Sale | 9,747 | $9.62 | $94K | -7% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $FENC feed.